Trials / NCT05853107
Pilot Study of AuTNA I
Recruiting now N/A Gene therapy, Retinal implant
- Sponsor
- Eye & ENT Hospital of Fudan University
- Treatment
- AuTNA I
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 70 Years
- Enrollment
- 7 participants
- Started
- 2023-05-12
- Main results expected
- 2026-02-28
- Results posted
- Not yet
- Record last updated
- 2025-09-19
What the study is testing
The objective of the study is to evaluate:
- Safety of AuTNA I for subretinal implantation in patients with retinitis pigmentosa;
- Efficacy of AuTNA I for subretinal implantation in patients with retinitis pigmentosa.
Where it runs
China (1)
- Chunhui Jiang, Shanghai, Shanghai Municipality (recruiting now)